American Trust Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
American Trust Investment Advisors's LLY Position: Q1 2026 in Review
American Trust Investment Advisors reduced its Eli Lilly (LLY) stake by 7% in Q1 2026, selling an estimated $62.9K and leaving 820 shares worth $754K. The position accounts for 0.42% of the portfolio, ranked #43.
American Trust Investment Advisors first reported a position in LLY in Q2 2018 and has held it in 27 quarters since. The position peaked at $948K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- American Trust Investment Advisors held 820 shares of Eli Lilly worth $754K as of Q1 2026.
- American Trust Investment Advisors sold 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
- Eli Lilly made up 0.42% of American Trust Investment Advisors's portfolio in Q1 2026, its #43 holding.
- American Trust Investment Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 27 quarters since.
- American Trust Investment Advisors's Eli Lilly position peaked at $948K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on American Trust Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.